Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin's Lymphoma: Recent Advances and Outcomes.

Al-Juhaishi, Taha; Borogovac, Azra; Ibrahimi, Sami; Wieduwilt, Matthew; Ahmed, Sairah

Al-Juhaishi, Taha; Borogovac, Azra; Ibrahimi, Sami; Wieduwilt, Matthew; Ahmed, Sairah.

Afiliación

Al-Juhaishi T; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK 73104, USA.
Borogovac A; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK 73104, USA.
Ibrahimi S; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK 73104, USA.
Wieduwilt M; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK 73104, USA.
Ahmed S; MD Anderson Cancer Center, University of Texas, Houston, TX 77030, USA.

J Pers Med ; 12(2)2022 Jan 18.

Article en En | MEDLINE | ID: mdl-35207613

Palabras clave

Hodgkin's lymphoma; allogeneic hematopoietic stem cell transplant; autologous hematopoietic stem cell transplant; high-dose chemotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Pers Med Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google